European regulator recommends approval of Carvykti in earlier lines of multiple myeloma
A European Medicines Agency committee recommended that the label for Legend Biotech and Johnson & Johnson’s CAR-T Carvykti be expanded to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
